ArticleMetabolic brain disease2025
Effects of chronic social defeat stress on behavior and cognition by activating the ERS-NLRP3 signaling pathway in adult mice.
Article in Metabolic brain disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Social defeat stress induces behaviors associated with both depression and anxiety in animals, but the mechanisms involved remain inadequately understood. This study aimed to examine the effects of social defeat stress on anxiety-related behaviors and cognitive impairments via the activation of the endoplasmic reticulum stress (ER stress)-nuclear factor kappa-B (NF-κB)-NOD-like receptor thermal protein domain associated protein 3 (NLRP3) signaling pathway in adult mice. Adult mice were assigned to four groups: control, social defeat stress, social defeat stress + phenylbutyric acid (PBA), and tunicamycin (TM). Mice in the social defeat stress and social defeat stress + PBA groups underwent a 10-day social defeat protocol, while the TM group received a 2 mg/kg intraperitoneal injection of TM. Dopamine (DA) and 5-hydroxytryptamine (5-HT) levels were measured using ELISA. Behavioral assessments were followed by Western blotting and immunofluorescence staining to evaluate changes in the ER stress-NLRP3 pathway in the medial prefrontal cortex (mPFC). Social defeat stress induced anxiety-like and depression-like behaviors and impaired memory function in all stressed mice. It also increased the expression of ER stress markers, activated NF-κB, and triggered the NLRP3 inflammasome. The ER stress inhibitor PBA alleviated these effects. The results indicate that social defeat stress induces anxiety-like, depression-like behaviors, and cognitive dysfunction in mice, with the activation of the ER stress-NF-κB-NLRP3 pathway in the mPFC playing a critical role in these outcomes. Inhibition of ER stress reduced NLRP3 inflammasome expression via NF-κB, thereby mitigating cognitive deficits and improving anxiety-and depression-like behaviors.
Indexed as
Identifiers
41405659What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.